GlassScriptPhysician profile
Richard Gamiz
NPI 1558323444
$2,452.01
in general payments reported to CMS, 2019-2025
20 companies · $620 in 2025
The $620 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $580 · 2023: $677 · 2024: $350 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,646.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $587.60 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Ascenda |
| Spr Therapeutics, INC | $327.51 | 2023-2025 | Sprint Pns System |
| Boston Scientific Corporation | $299.95 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16, General - Therapies |
| Abbott Laboratories | $234.42 | 2021-2024 | Proclaim, Eterna |
| Foundation Fusion Solutions, LLC | $157.25 | 2025 | |
| Braeburn INC. | $121.85 | 2024 | Brixadi |
| Si-Bone, INC. | $99.51 | 2021-2023 | |
| Lundbeck LLC | $95.24 | 2022-2024 | Vyepti |
| Abbvie INC. | $95.06 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.33 | 2021-2022 | |
| Painteq LLC | $88.71 | 2023-2024 | Painteq |
| Radius Health, INC. | $51.31 | 2021 | |
| Globus Medical, INC. | $44.92 | 2025 | Acp |
| Biohaven Pharmaceutical Holding Company LTD. | $43.54 | 2022 | |
| Protega Pharmaceutials INC | $23.58 | 2023 | Roxybond |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $21.32 | 2024 | Senza |
| Lilly USA, LLC | $18.36 | 2022 | |
| Eisai INC. | $18.02 | 2021 | |
| Bioventus LLC | $17.38 | 2022 | |
| Idorsia Pharmaceuticals US INC | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Gamiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.